What is NDT Pharmaceuticals Inc. (NDTP)?

NDT Pharmaceuticals Inc. (NDTP) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

What is the current price of NDTP?

The current price of NDTP is $0.35. Prices are updated in real time on Stocks360.

What is NDTP's price-to-earnings (PE) ratio?

NDTP's trailing twelve-month PE ratio is -68.63, based on current price and earnings per share data available on Stocks360.

What is NDTP's market capitalization?

NDTP's market capitalization is $56,001,523.00, placing it in the small-cap tier.

NDT Pharmaceuticals Inc. (NDTP)

Stock analysis · OTC · Healthcare · Biotechnology

$0.35

Market Cap

$56.00M

PE (TTM)

-68.63

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.00

Day Range

$0.25 – $0.35

52-wk Range

$0.24 – $2.10

Avg Volume

N/A

Volume

5.61K

NDT Pharmaceuticals Inc. (NDTP) is a publicly traded company in the Healthcare sector. Latest price: $0.35. Market cap $56.00M. Trailing PE -68.63. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-09-16 · $0.83 2026-09-15 · $0.35 (-57.84%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About NDT Pharmaceuticals Inc.

NDT Pharmaceuticals Inc., a biotechnology firm situated in Vienna, Virginia, is dedicated to formulating a range of treatments for serious neurological ailments, particularly those stemming from traumatic brain injuries.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-68.63×
P/S (TTM)	201.11×
P/B	1.77×
PEG	0.29×
P/FCF (TTM)	-119.15×
EV / EBITDA	-89.62×
EV / Sales	203.33×
Earnings Yield	-1.48%
Free Cash Flow Yield	-0.84%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$56.62M
Revenue (TTM)	$278.46K
Net Income (TTM)	-$826.60K
Free Cash Flow (TTM)	-$470.01K
Net Debt	$620.15K
Working Capital	$1.69M
Gross Margin	-145.05%
Operating Margin	-365.55%
Net Margin	-366.41%
Return on Equity	-5.17%
Return on Invested Capital	-2.56%